These results illustrate protein aggregation–mediated pathobiology of a hematopoietic disorder (Supplemental Figure 12F) and provide support to the notion of targeting aggrephagy pathways as an alternate therapeutic option for G-CSF–resistant SCN. Here, CSF3 is linked to severe congenital neutropenia.